Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-10-12
1993-05-04
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 4352351, 435236, 435237, 435239, 435 701, 435245, A61K 3912, C12N 700
Patent
active
052080234
ABSTRACT:
A process for preparation of an attenuated strain of avian encephalomyelitis virus ("AEV") which may be used as a component of a protective vaccine, which comprises the steps of infecting chick embryo fibroblast ("CEF") cells with AEV, culturing the AEV-infected CEF cells until the AEV has become adapted to the CEF cells and then isolating the AEV product from the CEF cells for use in the vaccine. An attenuated AEV strain produced in this way, and tests showing use as a vaccine in chickens are also described.
REFERENCES:
Bennjean et al., Biological Abstracts, vol. 63, (2), Ref. No. 9254, 1976.
Nicholas et al., Research in Veterinary Science, vol. 40, pp. 118-122, 1986.
Nicholas et al., Arch. Virol., vol. 96, pp. 283-287, 1987.
Nicholas et al., Biological Abstracts, vol. 82 (1), Ref. No. 4932, 1986.
Nicholas et al., Biological Abstracts, vol. 85 (2), Ref. No. 22926, 1987.
Goddard Roy D.
Nicholas Robin A. J.
Thornton Denise H.
Minister of Agriculture, Fisheries & Food in Majesty's Governmen
Mohamed Abdel A.
Wityshyn Michael G.
LandOfFree
Vaccine against avian encephalomyelitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine against avian encephalomyelitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against avian encephalomyelitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973817